Market Tracker

03/29 9:02am ET

SPDR® S&P Biotech ETF (XBI)

69.31
Delayed Data
As of Mar 28
 -0.44 / -0.63%
Today’s Change
47.88
Today|||52-Week Range
72.58
+17.10%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Performance

1 month-1.40% 3 years+15.44%
3 months+15.38% 5 years+21.56%
1 year+40.58% Since inception+14.13%
Data through 03/29/2017

Quote Details

Previous close$69.75
Open day’s range68.97 – 70.40
Net asset value (NAV)69.27 (03/28/2017)
Daily volume3,490,895
Average volume (3 months)5,376,286
Data as of 03/28/2017

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+21.56%+16.84%
Expense Gross exp ratio0.35%1.33%
Risk 5 year sharpe ratio0.821.11
Net assets$3.0B$3.0B
Average market cap$4.9B$30.5B
Average P/E--22.3
Dividend / Share--0.30%

Competitors

XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
CLVS Clovis Oncology Inc3.22%
KITE Kite Pharma Inc3.13%
TSRO TESARO Inc2.94%
ACAD ACADIA Pharmaceuticals Inc2.89%
EXAS Exact Sciences Corp2.83%
INCY Incyte Corp2.69%
EXEL Exelixis Inc2.60%
BLUE bluebird bio Inc2.56%
AMGN Amgen2.50%
ALNY Alnylam Pharmaceuticals Inc2.48%